SavedAdd your journal

Journals / European Journal of Therapeutics / 2019 / Cilt: 25 - Sayı: 1

Effects of Gabapentin on Carrageenan-Induced Inflammation, Acute Phase Reactants and Gastric Mucus Secretion in Rats

Cafer YILDIRIM
Başak DÖNERTAŞ
Fatma Sultan KILIÇ
Şule AYDIN
Bilgin KAYGISIZ
Setenay ÖNER
Pages
23–27
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: Both doses of GBP reduced paw thickness at 6 h (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Gabapentin (GBP), which was first developed as an anticonvulsant agent, has recently gained great attention considering its pain relieving and anti-inflammatory effects.
📊
Key Findings & Data:Methods: Paw edema was induced with 1% CAR immediately before intraperitoneal saline, GBP (10 or 30 mg/kg), and diclofenac (DIC) (5 mg/kg) injections.
💡
Conclusion & Impact:Results: Both doses of GBP reduced paw thickness at 6 h (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Gabapentin (GBP), which was first developed as an anticonvulsant agent, has recently gained great attention considering its pain relieving and anti-inflammatory effects. The aim of the present study was to investigate the anti-inflammatory effect of GBP on carrageenan (CAR)-induced paw edema and its gastric side effects by determining gastric mucus secretion in rats. Methods: Paw edema was induced with 1% CAR immediately before intraperitoneal saline, GBP (10 or 30 mg/kg), and diclofenac (DIC) (5 mg/kg) injections. Paw thickness was measured hourly during 6 h. Serum cytokine levels were determined using enzyme-linked immunosorbent assay. For evaluation of gastric mucus secretion, saline, GBP, and DIC were administered orally for 10 days. On day 10, stomachs were removed, and gastric mucus of the glandular part was evaluated spectrophotometrically. Results: Both doses of GBP reduced paw thickness at 6 h (p

🔖

Cite This Article

YILDIRIM, C., DÖNERTAŞ, B., KILIÇ, F. S., AYDIN, Ş., KAYGISIZ, B., ÖNER, S. (2022). Effects of Gabapentin on Carrageenan-Induced Inflammation, Acute Phase Reactants and Gastric Mucus Secretion in Rats. European Journal of Therapeutics, Cilt: 25 - Sayı: 1, 23–27. https://ajindex.com/articles/512259

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. Han C, Li XD, Jiang HQ, Ma JX, Ma XL. The use of gabapentin in the management of postoperative pain after total hip arthroplasty: a meta-analysis of randomised controlled trials. J Orthop Surg Res 2016; 11: 79. Kremer M, Salvat E, Muller A, Yalcin I, Barrot M. Antidepressants and gabapentinoids in neuropathic pain: Mechanistic insights. Neuroscience 2016; 338: 183-206.
  2. Doleman B, Heinink TP, Read DJ, Faleiro RJ, Lund JN, Williams JP. A systematic review and meta-regression analysis of prophylactic gabapentin for postoperative pain. Anaesthesia 2015; 70: 1186-204. U.S. Food and Drug Administration (FDA). Neurontin (Gabapentin) Medication Guide. (cited 2017 May 17) Available from: https://www. accessdata.fda.gov/drugsatfda_docs/label/2011/020235s036,0208 82s022,021129s022lbl.pdf. Abdi S, Lee DH, Chung JM. The anti-allodynic effects of amitriptyline, gabapentin, and lidocaine in a rat model of neuropathic pain. Anesth Analg 1998; 87: 1360-6.
  3. Rodrigues-Filho R, Campos MM, Ferreira J, Santos AR, Bertelli JA, Calixto JB. Pharmacological characterisation of the rat brachial plexus avulsion model of neuropathic pain. Brain Res 2004; 1018: 159-70.
  4. Heughan CE, Sawynok J. The interaction between gabapentin and amitriptyline in the rat formalin test after systemic administration. Anesth Analg 2002; 94: 975-80.
  5. Zhang WS, Xu H, Xu B, Sun S, Deng XM, Zhang YQ. Antihyperalgesic effect of systemic dexmedetomidine and gabapentin in a rat model of monoarthritis. Brain Res 2009; 1264: 57-66. Tjølsen A, Berge OG, Hunskaar S, Rosland JH, Hole K. The formalin test: an evaluation of the method. Pain 1992; 51: 5-17. 10. Coderre TJ, Katz J, Vaccarino AL, Melzack R. Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain 1993; 52: 259-85. 11. Mao J, Chen LL. Gabapentin in pain management. Anesth Analg 2000; 91: 680-7. 12. Dias JM, de Brito TV, de Aguiar Magalhães D, da Silva Santos PW, Batista JA, do Nascimento, et al. Gabapentin, a synthetic analogue of gamma aminobutyric acid, reverses systemic acute inflammation and oxidative stress in mice. Inflammation 2014; 37: 1826-36. 13. Tanaka T, Minami M, Nakagawa T, Satoh M. Enhanced production of monocyte chemoattractant protein-1 in the dorsal root ganglia in a rat model of neuropathic pain: possible involvement in the development of neuropathic pain. Neurosci Res 2004; 48: 463-9. 14. White FA, Bhangoo SK, Miller RJ. Chemokines: Integrators of pain and inflammation. Nat Rev Drug